Verismo Therapeutics, a clinical-stage CAR-T company developing novel KIR-CAR platform technology, today announced that it ...

Leukaemia & Lymphoma NI (LLNI) marked its 60th anniversary in style with a Black Tie and Diamonds Gala Ball, celebrating six ...

UI Health Care and Mission Cancer + Blood announce an agreement to create a $280M statewide cancer care network to tackle ...

Kyowa Kirin International (KKI), a wholly owned subsidiary of Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin), today announced it will present interim findings from three real-world studies in cutaneous ...

For patients with relapsed/refractory large B-cell lymphoma (LBCL), the autologous, CD19-directed, 4-1BB chimeric antigen ...

Chair of Tampa Light the Night, Laura Sherman, joins Gayle Guyardo, the host of the global health and wellness show, Bloom, ...

Patients with a rare blood cancer that has relapsed or become resistant to treatment have shown a high response rate to a ...

David Reitz has supported the Leukemia & Lymphoma Society with Light the Night walks raising over $46,000. This year he is ...

The FDA granted a priority review to acalabrutinib for the treatment of previously untreated adults with mantle cell lymphoma ...

Elicera Therapeutics describes how CAR T cells armed with neutrophil-activatingprotein can improve cancer therapy by inducing ...

An event aimed at spreading light and hope for patients and families dealing with the impacts of blood cancer returns Thursday.